Lawrence Korngut

Lawrence Korngut is the Co-Founder & Chief Medical Officer at OligomicsTx, a preclinical biotechnology company specializing in RNA-based therapies for rare diseases. Lawrence is also the Co-Founder and Chief Medical Officer at Lumiio Inc., a company focused on real-world data collection for health outcomes. In addition, Lawrence is a member of the Investment Advisory Group at UCeed Neuro Investment Fund and serves on the Scientific Advisory Board at SOLVE FSHD. With a background in neurology and clinical epidemiology, Lawrence holds various roles at institutions such as Hotchkiss Brain Institute, University of Calgary, and Creative Destruction Lab.